Type III-delivered exoenzyme S (ExoS) preferentially ADP-ribosylated membrane-associated His 6 HRas, relative to its cytosolic derivative His 6 HRas⌬CAAX. This indicates that the subcellular protein distribution contributes to in vivo ADP-ribosylation by ExoS.
generate pores within the plasma membrane for intracellular diffusion of [ 32 P]-NAD (Riese et al., submitted). Briefly, tetanolysin (0.4 g/ml) was applied to CHO cells in cold HGI buffer (1) (20 mM PIPES, 2 mM Na-ATP, 4.8 mM magnesium acetate, 0.15 M K-glutamate, 2 mM EGTA, KOH adjusted to pH 7.0) at 4°C for 10 min to permit binding to cell membranes. Cells were washed with cold HGI buffer and then incubated in HGI buffer containing [
32 P]-NAD (1 Ci/ml) at 37°C for 25 min. At this time, cells were harvested in HB2 buffer (0.25 M sucrose, 3 mM imidazole adjusted to pH 7.4, 0.5 mM EDTA, 2 g of phenylmethylsulfonyl fluoride per ml) and disrupted, and the nuclei and unbroken cells were removed by low-speed centrifugation. This postnuclear supernatant was centrifuged at 68,000 ϫ g for 30 min to produce membrane (pellet) and cytosol (soluble) fractions. Membranes were suspended in HB2 plus 1% Triton X-100.
Infection of CHO cells with ExoS-producing P. aeruginosa and subsequent incubation with tetanolysin and [ 32 P]-NAD resulted in preferential incorporation of radiolabel into 25-and 50-kDa proteins (Fig. 1A , CHO ϩ ttl). In addition to these radiolabeled proteins, infection of His 6 HRas-transfected CHO cells with ExoS-producing P. aeruginosa yielded a unique tetanolysin-dependent, radiolabeled protein, which migrated with an apparent molecular mass greater than the 25-kDa radiolabeled protein (Fig. 1A , arrow, CHO-His 6 Ras, ϩ ttl). This unique radiolabeled protein was identified as His 6 Ras based upon its immunoprecipitation with ␣-His 6 antisera (Fig. 1B) and reactivity to His probe by Western blot procedures (Fig.  1) . To address the possibility that the incorporation of radiolabel could be due to secreted ExoS or bacterially associated ExoS, but not translocated ExoS, pUCPExoSHA was transformed into P. aeruginosa deficient in type III translocation (PA103⌬pcrV) and the ability of this type III-deficient strain to deliver ExoS into CHO cells was determined. CHO cells infected with PA103⌬pcrV(pUCPExoSHA) did not incorporate radiolabel into Ras, using the tetanolysin assay system (data not shown). This showed that type III translocation was required for the observed incorporation of radiolabel into Ras and that bacterially delivered ExoS ADP-ribosylated His 6 HRas via a tetanolysin-dependent mechanism. In addition, subcellular fractionation preserved the ADP-ribosylation patterns observed in CHO cells harvested in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and boiled (data not shown), which indicated that little detectable modification had occurred after harvesting.
Membrane localization enhances the efficiency of the ADPribosylation of Ras by ExoS. The contribution of intracellular localization for efficient ADP-ribosylation by ExoS was addressed by measuring the efficiency of in vivo ADP-ribosylation of Ras, a membrane associated protein, and Ras⌬CAAX, a C-terminal deletion protein of Ras that localizes in the cytosol (3) . Subcellular fractionation showed that like endogenous Ras, 93% of the His 6 -HRas was in the membrane fraction, while 83% of His 6 -HRas⌬CAAX was present in the cytosol ( Fig. 2A) . Cotransfected green fluorescent protein (GFP) was FIG. 1. ExoS ADP-ribosylates His 6 -HRas in tetanolysin-treated CHO cells. CHO cells or pCMV-His 6 -HRas (3.0 g)-transfected CHO cells (85-mm-diameter dishes) were infected for 3 h with ExoS-producing P. aeruginosa. Cells were then incubated for 10 min at 4°C, alone or with 2.4 g of tetanolysin in 6 ml of HGI buffer, and washed with ice-cold HGI buffer. Next, 6 ml of HGI buffer containing 6 Ci of 20 nM 32 P-NAD was added and cells were placed at 37°C in 5% CO 2 . Cells were harvested and broken, and the postnuclear supernatant was fractionated into cytosol and membrane components. (A) Membrane fractions were subjected to SDS-PAGE, transferred onto polyvinylidene difluoride (PVDF), and exposed to X-ray film (upper panel; the arrow indicates the unique radiolabeled 28-kDa protein), or blotted with His 6 -Probe (lower panel). (B) Membrane fractions were subjected to immunoprecipitation, using ␣-His 6 antibody. The immunoprecipitate was subjected to SDS-PAGE, transferred to PVDF, and analyzed by autoradiography (upper panel; the arrow indicates the unique radiolabeled 28-kDa protein) or His 6 -Probe blotting (lower panel). 
ng). (B to C) CHO cells in 12 wells
were transfected with the indicated amounts in micrograms (Amt) of pHis 6 -HRas or pHis 6 -HRas⌬CAAX for 18 h. Cells were infected with a control strain of P. aeruginosa that did not express ExoS (panel B, lane pUCP) or an ExoS-producing P. aeruginosa (panel B, lane pUCPExoS, and panel C, all lanes) for 3.5 h, treated with tetanolysin and then 32 P-NAD (see Fig. 1 ). Cell lysates were prepared and subjected to SDS-PAGE and autoradiography (upper panel; the arrow indicates ADP-ribosylated His 6 Ras) or immunoblotting with ␣-Ras IgG as the primary antibody (lower panel). (D) CHO cells were transfected with 1.5 g of pHis 6 -HRas or 3 g of pHis 6 -HRas⌬CAAX and harvested. Ten microliters of postnuclear supernatant was incubated with the indicated nanomolar amount of ExoS (232 to 453), 0.2 M fatty acid synthase, and 0.1 mM NAD in a 20-l reaction volume of 50 mM Tris-HCl, pH 8.0. After 15 min at room temperature, reactions were stopped by the addition of sample buffer and subjected to SDS-PAGE. Proteins were transferred to PVDF and subjected to enhanced chemiluminescence with ␣-Ras. Data from panels C and D are quantified in Table 1 .
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on September 7, 2017 by guest http://iai.asm.org/ present in the cytosol, which indicated that the fractionation produced little contamination of cell membranes in the cytosol ( Fig. 2A) . Treatment of transfected cells with tetanolysin did not alter the distribution of His 6 -HRas or His 6 -HRas⌬CAAX (data not shown). His 6 -HRas-or His 6 -HRas⌬CAAX-transfected CHO cells were infected with ExoS-producing P. aeruginosa. Western blot analysis showed that only a small amount of His 6 -HRas and endogenous Ras was shifted during infection, making quantitative analysis of protein modification difficult. This also indicated that at this time point of analysis, substantial in vivo ADP-ribosylation of Ras or Ras⌬CAAX had not yet occurred. Thus, in vivo ADP-ribosylation of the two forms of Ras was determined by direct ADP-ribosylation. After 3.5-h infections, cells were treated with tetanolysin and [ 32 P]-NAD. When normalized for protein expression, His 6 -HRas was observed to be radiolabeled 20-fold more efficiently than His 6 -HRas-⌬CAAX ( Fig. 2C and Table 1 ). Controls showed that, in vitro, both His 6 -HRas and His 6 -HRas-⌬CAAX were ADP-ribosylated by ExoS at similar rates ( Fig. 2D and Table 1 ), which indicated that ExoS did not have an intrinsic preference for either form of Ras. Together, these data showed that membrane localization enhanced the efficiency for ADP-ribosylation of Ras by type III-delivered ExoS.
ExoS is enriched in the membrane-associated fraction. Distribution of ExoS in infected cells was determined by physical and enzymatic measurements. Western blot analysis of subcellular fractions of GFP-transfected CHO cells infected with ExoS-producing P. aeruginosa showed that 86% of ExoS was associated with the membrane fraction, while 14% was in the cytosol (standard deviation [SD], Ϯ6% from two independent determinations). Localization of functional ExoS was determined on cell fractions from CHO cells infected with ExoSproducing P. aeruginosa, using soybean trypsin inhibitor as a target and the cell lysates as a source of ExoS as previously described (10) . From this assay, membranes possessed 90.2%, while the cytosol possessed 9.8% (SD, Ϯ1.8% from two independent determinations) of the ADP-ribosyltransferase activity in the postnuclear supernatant.
Conclusion. Type III-delivered ExoS was found to be localized to the membranes of infected CHO cells by functional and physical analysis. Type III-delivered ExoS preferentially ADPribosylated membrane-associated His 6 HRas, relative to its cytosolic derivative His 6 HRas⌬CAAX. This indicates that target protein localization contributes to the in vivo ADP-ribosylation of proteins by ExoS. a Data are compiled from three independent experiments. For in vivo experiments, ADP-ribosylated His 6 Ras was determined from densitometry of autoradiograms as described for Fig. 2C (upper panel) relative to expression of His 6 Ras assessed from densitometry of ␣-Ras Western blots as depicted in Fig. 2C (lower  panel) ; values are in arbitrary units of radiolabel-incorporated His-Ras expression. For in vitro ADP-ribosylation, the percent His 6 Ras (of total His 6 Ras) present in the slower migrating form was quantitated from addition of 1.7 nM ExoS as depicted in Fig. 2D from five independent experiments. Quantitation of two 0.56 nM ExoS experiments produced values of 14% (Ϯ 8%) shifted His 6 Ras and 18% (Ϯ 6%) shifted His 6 Ras ⌬CAAX.
